The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — including colorectal, gastric, kidney and liver cancer — is also on the rise, though cancer among patients under 50 is still relatively rare overall, Dr. Partridge said.

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic breast cancer who had progressed on multiple line of therapy.

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

Dr. Wayne Frederick joins The Lead

There is better detection and treatments for cancer these days, and that helps save lives. The American Cancer Society released a new report on Thursday that finds cancer deaths are dropping, but it also found an increase in young and middle-aged women getting diagnosed.

It appears mortality rates for cancer are continuing to decline. According to the American Cancer Society’s annual report, there was a 34% decrease in deaths between 1991 and 2022. And